metformin has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babu, E; Ganapathy, V; Ho, HT; Itagaki, S; Wang, J; Zhou, M | 1 |
| Anson, RM; de Cabo, R; Ingram, DK; Lane, MA; Mamczarz, J; Mattison, J; Roth, GS; Zhu, M | 1 |
| Ghumatkar, PJ; Jain, PD; Patil, SP; Sathaye, S; Tambe, R | 1 |
| Han, C; Waddington, JL; Wang, G; Yan, Q; Zhen, X; Zheng, L | 1 |
1 review(s) available for metformin and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Development of calorie restriction mimetics as a prolongevity strategy.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Body Temperature; Caloric Restriction; Deoxyglucose; Dopamine; Dopamine Agents; Glycolysis; Humans; Insulin; Longevity; Metformin; Oligonucleotide Array Sequence Analysis; Rats; Time Factors; Up-Regulation | 2004 |
3 other study(ies) available for metformin and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter.
Topics: Animals; Cell Membrane; Electrophysiological Phenomena; Equilibrative Nucleoside Transport Proteins; Female; Humans; Membrane Potentials; Organic Cation Transport Proteins; Xenopus laevis; Xenopus Proteins | 2012 |
Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Catalase; Glutathione; Lipid Peroxidation; Male; Metformin; Mice; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Random Allocation; Rotarod Performance Test; Substantia Nigra; Superoxide Dismutase; Tyrosine 3-Monooxygenase | 2014 |
Activation of AMPK/mTORC1-Mediated Autophagy by Metformin Reverses Clk1 Deficiency-Sensitized Dopaminergic Neuronal Death.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; AMP-Activated Protein Kinases; Animals; Autophagy; Cell Survival; Cells, Cultured; Dopamine Agents; Dopaminergic Neurons; Enzyme Activators; Mechanistic Target of Rapamycin Complex 1; Membrane Proteins; Metformin; Mice; Mice, Mutant Strains; Mitochondrial Proteins; Mixed Function Oxygenases; Pars Compacta | 2017 |